18 hours Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Allogene Therapeutics (ALLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
X